Follow up studies showed that 13 infants were handicapped with nine severely handicapped. Extreme prematurity, the need for early or repeated resuscitation using these drugs, particularly for episodes of collapse without a clear precipitating cause, and asystole rather than bradycardia were associated with a worse outcome. Evidence is accumulating to support a view that the use of these drugs for resuscitation at birth and in the first week of life of extremely preterm infants may be inappropriate.
Active resuscitation of infants is most commonly required at the time of birth, or for intercurrent episodes of collapse during neonatal intensive care. The causes of sufficient collapse to need such intervention are many and varied. Many episodes of deterioration respond quickly to the establishment or reestablishment of adequate ventilator support, external cardiac massage, treatment of the cause of the collapse -for example, drainage of a pneumothorax -administration of alkali, and volume expansion. Adrenaline or atropine, or both, may also be used during resuscitation, and the need for these drugs suggests a more severe and treatment resistant episode of collapse.
Few reports have been published on outcome when adrenaline or atropine, or both, are used in the context of modern neonatal intensive care.' 2 A report in 1988 on the outcome of cardiopulmonary resuscitation of infants with birth weights less than 1500 g showed that the overall outcome was poor and suggested that cardiopulmonary resuscitation was a nonvalidated treatment in the population of infants studied.1 Indeed, the subtitle of the paper asked whether such resuscitation was futile.
Against this background we now report our experience in the use of adrenaline or atropine, or both, during resuscitation in the newborn period and the early weeks of life.
Methods A five year retrospective study has been carried out on those infants who were treated with adrenaline or atropine, or both, either as part of (a) resuscitation at delivery with response enabling admission to the neonatal medical unit or (b) resuscitation during their stay on the neonatal unit, or both.
All patients under the care of one of the authors (DGS) have a clinical abstract completed when they leave the regional neonatal medical unit at this hospital. This Decisions about the use of adrenaline or atropine, or both, during a particular episode of resuscitation were the responsibility of the attending clinician rather than adherence to a set procedure.
Results
During the five year study period 1 144 patients were admitted to the care of the consultant firm. One hundred and seventy three (1 5 -1 %) were of 28 weeks' gestation or less with 71 deaths (41%), 266 (23-3%) of between 29 and 32 weeks' gestation with 17 deaths (6%), 332 (29%) of between 33 and 36 weeks' gestation with nine deaths (3%), and 373 (32-6%) of 37 weeks' or more with 24 deaths (6%).
Adrenaline was administered as part of resuscitation to 98 patients, in 40 (41%) of whom it was given in combination with atropine. A small group of seven patients received atropine alone, giving a total study Eighteen infants received adrenaline alone and two received atropine alone as part of birth resuscitation. The gestational age range was 24-42 weeks (mean (SD) 34-3 (6-2)) and the birth weight range was 530-5300 g (2335 (1244)). Table 1 gives the clinical details by gestational age groups. These infants had all been intubated by 5 minutes after birth. The route of administration of adrenaline was noted in 16 patients and was variously given by the intravenous (six), intracardiac (five), or endotracheal tube (10) route, three infants receiving it by two routes and one by three routes. A prompt response was noted in eight infants. Atropine was only given intravenously. The cause of the poor condition at birth was variable in the two more preterm groups and included antepartum haemorrhage, rhesus hydrops, loss of the fetal heart before delivery, and unexpectedly poor condition at birth. The infant at 33-36 weeks' gestation had a myopathy, and the infants at 37 weeks or more all had fetal bradycardias, most with meconium staining, one with loss of the fetal heart before delivery, and one with shoulder dystocia. Table 2 gives details of the illnesses present after transfer to the neonatal unit, together with specific treatments offered across the four gestational age groups. Table 4 gives details of the gestational age, birth weight, main illnesses suffered by 20% or more of these infants, and the main treatments offered. As expected, as problems due to surfactant deficient lung disease and extreme prematurity decreased, so those due to congenital malformations increased with rising maturity. The congenital abnormalities included five infants with complex congenital heart disease, one with a simple atrial septal defect, one with an absent pituitary gland and adrenal hypoplasia, and one with the rib gap syndrome. Table 5 gives the age at which the infants had their first major collapse requiring treatment with adrenaline or atropine, or both, together with the main causes of collapse. It also shows the number of infants who responded to such resuscitation by surviving for at least 12 hours but who ultimately died, and the number and condition of those who were long term survivors. The total periods of survival from resuscitation to death in those infants who survived at least 12 hours from resuscitation were: -28 weeks, 143 days; 29-32 weeks, 13 days; and -37 weeks, 84 days. The main causes of the episodes of collapse necessitating intense resuscitation are given. The miscellaneous group includes infants who collapsed with intraventricular haemorrhage associated with increased fontanelle tension and convulsions, those who group.bmj.com on October 27, 2017 -Published by http://fn.bmj.com/ Downloaded from deteriorated because of renal failure with hyperkalaemia and hypoglycaemia, collapse associated with subglottic stenosis, collapse after intravenous phenytoin treatment, and collapse with abdominal distension and anaemia in an infant who already had significant bronchopulmonary dysplasia.
Fifty seven infants had at least one cranial ultrasound scan during their stay on the neonatal medical unit. Thirty (53%) had their only scans before or about at the time of their episode of major collapse, nine (16%) had their only scan after the episode of collapse, and 18 (32%) had scans before and after the collapse. Within the group who only had scans before the collapse 16 (53%) showed normal appearances or subependymal haemorrhage only, seven (23%) intraventricular haemorrhage, three (10%) intraventricular haemorrhage with ventriculomegaly, three (10%) isolated ventriculomegaly, and one (3%) periventricular leukomalacia.
Two of the group of nine infants (22%) who had ultrasound scans only after their collapse had a normal appearance, one (11%) intraventricular haemorrhage, two (22%) intraventricular haemorrhage with ventriculomegaly (plus periventricular leukomalacia in one), two (22%) intracortical blood (one with later periventricular leukomalacia and cerebral atrophy), one ventriculomegaly, and one bright thalami.
In the group who had scans both before and after their collapse four (22%) were normal before, one (6%) showed subependymal haemorrhage, two (11%) intraventricular haemorrhage (one with periventricular leukomalacia), five (28%) showed intraventricular haemorrhage with ventriculomegaly (one with periventricular leukomalacia), three (17%) showed intracortical blood (one with periventricular leukomalacia), one (6%) showed periventricular leukomalacia alone, one bright thalami, and one ventriculomegaly with atrophy. Scans 
and 11 ( 17%) survived, seven (11%) being normal and four (6%) handicapped.
Fifty two (64%) infants were clearly documented in the notes as receiving external cardiac massage. Retrospective review suggests that in seven to nine infants the use of adrenaline or atropine, or both, without external cardiac massage was a gesture at resuscitation, as in the case of an infant dying of complex congenital cyanotic heart disease. The consultant cardiologist, when telephoned about the infant's deterioration, stated nothing further could be done. This comment was recorded in the casenotes yet the resident clinician still gave adrenaline. Other infants in this group were treated when in terminal metabolic derangement with congenital septicaemia or when they already had sclerema or massive intraventricular haemorrhage with convulsions. In other casenotes there were references to 'full CPR' (cardiopulmonary resuscitation), or it was clear that aggressive resuscitation was taking place with the siting of intravenous lines, insertion of chest drains or pericardial drains, reintubation, ordering blood transfusions, and at times carrying on resuscitation for up to one hour. Three infants not clearly documented as having external cardiac massage went on to become normal survivors and three were handicapped survivors.
The route of administration of adrenaline was clearly documented in 50 (66%) of the 76 infants who received it. The most commonly used route was intravenous: 39 (51%) patients (23 (30%) only by this route), followed by 19 (25%) who received it via endotracheal tube (seven (9%) only by this route), and 13 (1 7%) who received it by intracardiac injection, none receiving it only by that route. Thirty three (43%) infants only received adrenaline via one route, 13 (17%) via two routes, and four (5%) via all three routes.
In most of the remainder who received adrenaline it has to be assumed that the intravenous route was used in 22 instances, as the drug is documented among several other agents given intravenously, and via the endotracheal tube in one. Only in three instances was there no clue to the route of administration. Atropine was given to 44 patients and in 29 (66%) the route was clearly documented, being intravenous in 27 (6l1%), intracardiac in one (2%), and via the endotracheal tube in one. In 12 instances the route of administration was assumed to be intravenous for reasons given above and in three instances there was no clear indication of the route used. Three infants with gestational ages of 25-27 weeks and birth weights of 700-770 g, together with an infant with non-rhesus hydrops with a birth weight of 2320 g at 31 weeks' gestation formed this group, who all received adrenaline at birth. In addition, all had been resuscitated at delivery with endotracheal intubation, and three had received treatment with alkali. The three extremely preterm infants all had surfactant deficient lung disease. All four in this group received ventilator support. The episode of collapse requiring repeat treatment (adrenaline in four and atropine in one) occurred between the ages of 1-75 and 34 hours of life. The length of survival after resuscitation was at most eight hours and all had died by the age of 42 hours.
Discussion
The indications for, doses of, and best route of administration of adrenaline and atropine during resuscitation in very early life remain unclear. For example, one standard British textbook of neonatology gives, in different sections of the book, different doses of the two drugs for resuscitation purposes.3
Intravenous or intracardiac administration have been accepted routes in the past.
Endotracheal tube administration of adrenaline during resuscitation at birth has been suggested as the most rapidly effective route,4 and the same route for atropine has been shown to be as effective as the intravenous route in older children.5 As our data show, all or some of these routes may be used during a single attempt at resuscitation.
A review paper on resuscitation of newborn infants refers to the use of adrenaline without reference to long term outcome.6 There is no specific reference to the use or value of adrenaline or atropine in the section on resuscitation of preterm infants. Two large review papers on cardiopulmonary resuscitation of low Apgar score newborn7 or stillborn infants8 do not refer to the frequency with which adrenaline or atropine had been used in resuscitation, nor their relation with eventual outcome.
As the expertise and treatments used in the care of sick neonates improve and the gestational age of viability decreases, it is important that treatments, including those that have been available for a long time, undergo detailed evaluations. The availability of a particular treatment does not imply its efficacy or appropriateness in ever changing situations. Cardiopulmonary resuscitation, which includes the use of adrenaline or atropine is one such treatment and Lantos et al, in their study of very low birthweight infants, suggested that it was a non-validated treatment which might be considered futile.' Our study covers a wider population than that of Lantos et al and although it is not possible to conclude that the use of adrenaline or atropine as part of resuscitation is non-validated in all situations, it is clear that there are groups of patients and situations where its use should be questioned.
It may be difficult to withhold a readily administered treatment and it might be argued that nothing is lost by giving such a treatment in situations where there is little or no hope. With the above in mind it would be helpful to be able to predict those infants where the use of adrenaline or atropine might be considered inappropriate.
Twenty infants, five stillborn and 15 on the neonatal unit, were asystolic. Three of these survived and all were handicapped.
In infants treated only on the neonatal medical unit there were eight survivors in the group of -28 weeks' gestation and of these four were handicapped, which includes all of those treated at the age of less than one week. In the 29-32 weeks' gestation group there were only two survivors and the infant treated before the age of 48 hours is handicapped. Our finding of a poor overall outcome for the most preterm and smallest infants who require such resuscitation early in life agrees with the few other published reports. ' 2 Ten (77%) of the 13 survivors in the neonatally treated group had a correctable precipitating cause -that is, pneumothorax or blocked tube -and of these infants six are normal on follow up and four handicapped (two of the latter were s,28 weeks' gestation and treated within one week of birth, and one 29-32 weeks' gestation and treated within 48 hours). Two of the other three survivors required resuscitation due to an overall decline in condition -both of these were handicapped -and one required resuscitation after collapse during a clinical procedure (now normal).
Therefore the failure of very preterm infants who collapse in the earliest days of life to respond promptly to correction of the cause of their collapse -that is, drainage of a pneumothorax or re-establishment of a secure airway with use of alkali and volume expansion as appropriate -could be considered an indication to withdraw care. This may also be appropriate management for the very preterm infant aged several weeks or months who has a major deterioration when still affected by another significant life threatening disease. At gestational ages of 33 weeks or more, however, the use of adrenaline or atropine may result in a normal infant even when used in the first days of life. In conclusion, the following factors have been found to be associated with a poor outcome: extreme prematurity; early need for or repeated resuscitation with adrenaline or atropine, or both; the absence of clear precipitating factors causing the collapse needing resuscitation; and asystole rather than bradycardia. In the presence of any, and especially combinations, of these factors the attending clinician can reasonably question whether or not the use of adrenaline or atropine, or both, is justified. Evidence is now accumulating to support a view that the use of adrenaline or atropine, or both, for resuscitation in the first week of life in extremely preterm infants may be inappropriate and if an infant does not respond to the correction of an easily treated underlying problem, this can be considered to be an indication to withdraw support. A detailed and helpful review of the ethical aspects of cardiopulmonary resuscitation in paediatric practice has now been published.9
We are grateful for the secretarial help of Maureen Jones. This is a clinical paper, but there are also moral and legal arguments to take into account when faced with dilemmas of this sort. It is useful to be able to turn to first principles. The interests of the child are paramount, a concept with which paediatricians are comfortable.
From this we can establish a hierarchy of responsibilities and recognise that the interests of parents, though undoubtedly important, are secondary. The interests of society, and here the financial implications of intensive support may be included, take third place.
But what are the best interests of the child? To answer this we must first establish as precise a prognosis as possible. Sims et al have helped us with this: the overall outcome in the group described was very poor. The use of cranial ultrasound may have allowed the prognosis to be even more precisely defined for the individual.
The problem with the authors' recommendation that 'the failure of very preterm infants who collapse in the earliest days of life to respond promptly to correction of the cause of their collapse . . . could be considered an indication to withdraw care' is that it is often the most junior and inexperienced member of the team who has to decide to institute resuscitation.
The withdrawal of intensive support is not a decision to be made by a relatively inexperienced doctor on his or her own in the middle of the night. It is a decision that requires the full participation of the medical team, the nurses who are involved with the care of the baby, and the parents. The parents' views are most important: the baby cannot tell us what he or she wants, and generally it is the parents who are considered to be the people who have the best interests of their child most at heart, provided they have been informed as fully as possible of the prognosis by their baby's medical attendants. The process has been well described by Whitelaw et al.I If any of the discussants take the line that it would not be appropriate to stop intensive support, full support is continued, although discussions about its appropriateness should also continue.
What is the position of the law? There are at least two fairly recent cases relating to neonates. In the first (baby C)2 the court allowed intensive support to be withdrawn from a baby whose outlook was considered to be extremely poor, and in the second (baby J)3 a decision by the High Court judge was made for it not to be instituted. Both judgments were upheld by the Court of Appeal. In both cases it was evident that a clear idea of the prognosis, as established by the use of scientific techniques and clinical experience, was essential in deciding how best to proceed.
